No results displayed.
Inside "Drug Reference":
@CancerQuest on Twitter:
Related to this page:
Was this page helpful?
|
CancerQuest > Drugs > Alpha-interferon (Intron®, Roferon®-A)
Page 1 of 1 | <Previous : Next> Jump to Page:

Alpha-interferon (Intron®, Roferon®-A)

Generic Name: Alpha-interferon
Brand Name(s): Intron®, Roferon®-A
IUPAC:
FDA Approval: yes
Manufacturer Link
Usage: Alpha-interferon is given as an injection under the skin, usually in the abdomen or thigh. Alpha-interferon is used to treat kidney (renal) tumors, melanoma, multiple myeloma, carcinoid tumors and some types of lymphoma and leukemia.(1)(2)(3) Recombinant alpha-interferon is also used to treat hepatitis infections (Rebetron®, Rebetol®).

Mechanism: Alpha-interferon is a naturally occurring protein that is found in the body in small amounts. There are three types of interferon (alpha, beta and gamma). They are all involved in regulating the immune response. Alpha-interferon is thought to enhance the immune response against cancer cells, slow cancer cell division and reduce the ability of cancer cells to avoid recognition by immune cells. It is also be investigated for its ability to prevent the development of blood vessels (angiogenesis). The two drugs made from alpha-interferon, Intron® and Roferon®-A are slightly different forms of the protein.

Side Effects: Side effects are not usually severe but may include: flu-like symptoms, fatigue, vomiting and loss of appetite. Less common side effects include skin irritation, dizziness, depression, hair loss, anemia, an increased susceptibility to infection, and an altered heart rhythm. Both men and women may experience infertility during treatment.(1)

Contraindications: Interferon can worsen existing mental health problems and heart problems.

Page 1 of 1
Last Modified: 10/10/2010 Print Email Page Share
References for this page:
  1. "Interferon." MacMillan Cancer Support. (Accessed 10/5/2010). [http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Biologicaltherapies/Interferon.aspx]
  2. Ferrantini M, Capone I, Belardelli F. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie. 2007 Jun-Jul;89(6-7):884-93. Epub 2007 Apr 21. [PUBMED]
  3. Ravaud A, Dilhuydy MS. Interferon alpha for the treatment of advanced renal cancer. Expert Opin Biol Ther. 2005 Jun;5(6):749-62. [PUBMED]
Copyright ©2012 Emory University. All rights reserved.
Direct questions and comments to cancerquest@emory.edu.
Disclaimer | Legal Policies | Contact
Follow @CancerQuest on Twitter
CancerQuest Dictionary
Follow us on: